Article · 13 Feb 2026
Conference abstractPublished 21 Oct 2013
External price referencing system - Implementation in Albania and consequences
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
External Price Referencing was introduced in Albania during 2012 as a system that would contribute towards the principle of macroeconomic efficiency by exerting pressure on price. It was a fact that prices in Albania were far higher that the prices in the neighbor countries so this reform was an important step to a better price control. Provisions concerning regulatory changes that were made in order to implement this system, can be found in the Decision No. 62 of 1 February 2012 on the Way of Functioning of the Drug Pricing Commission and Order No 185/1 by the Minister of Health of 4 June 2012 on Approval of the Regulation on Methodology of Determination of Drug Prices and Administration Way of Price Declarations in the Republic of Albania. According to the Decision No. 62, CIF prices in Albania are compared to CIF prices of three reference countries: Italy, Greece and Macedonia. Implementation of External Price Referencing started after Price declarations for 2013. Price declarations were followed by negotiation meetings at the Ministry of Health of Albania, where the pharmaceutical companies were informed on products that exceeded the prices in the Reference Countries and were advised to lower prices according to the legislative demands. After the presentation of the regulatory framework and in practice application a simple analysis on tendency of prices over the years will follow in order to reflect the practical consequences of this reform in Albania.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ledia Cikopana”

